CTRI/2024/03/064273招募中Unknown
Acute hemodynamiC response To Carvedilol predicts survival in ACLF patients –ACT - C ACLF study ? - ACT - C ACLF Study
试验速览
- 阶段
- Unknown
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Age 18–70 yrs
- •2.ACLF diagnosis (AARC criteria)
排除标准
- •1.Contraindications to NSBB (Heart rate less than 65 per min, BP less than 110 by 65 mm Hg, Asthma, Heart failure, AKI, Large ascites, SBP, S. Na less than 125)
- •5.HE grades 2 to 4
- •6.NSBB therapy within 5 days
- •7.Pregnancy
- •8.Lactation
- •9.Planned for LT in the next 12 weeks
- •10.No consent.
研究者
相似试验
招募中
不适用
Carvedilol (drug) for liver diseaseCTRI/2022/01/039527Institute of Liver and Biliary Sciences
招募中
Unknown
Response to Carvedilol (drug) in Children With Clinically Significant Portal Hypertension (Liver Disease)CTRI/2023/03/050334Institute of Liver and Biliary Sciences
招募中
不适用
Acute Hemodynamic Response to Carvedilol in Predicting Survival in Acute on Chronic Liver Failure Patients - A Pilot Study.Acute on Chronic Liver FailureNCT05180292Institute of Liver and Biliary Sciences, India50
招募中
3 期
Evaluation of the effect of carvedilol in patients with gastrointestinal cancerGastrointestinal cancers (Esophageal cancer, Gastric cancer, Pancreatic cancer, Colon cancer).Malignant neoplasm of stomachIRCT20200907048646N1Ardabil University of Medical Sciences60
招募中
3 期
Effect of Carvedilol on Reducing Transtosomab Cardiac ComplicationsIRCT20190628044046N1Tehran University of Medical Sciences60